Deals and Financings Suzhou MediLink Therapeutics out-licensed global rights (ex-China) for its antibody-drug conjugate candidate against Human Epidermal Growth Factor Receptor 3 (HER3) to...
By Jonathan Saul and Ari Rabinovitch JERUSALEM (Reuters) – The backlog of ships is growing at Israeli ports while operations continue at most terminals...